Use in RXA-5-administered code to identify the particular vaccine administered. The codes listed are used by state health departments in the U.S. Entries will be added as needed to accommodate international requirements.
Table 0292 - Vaccines administered (code = CVX)(parenteral, unless oral is noted)
Code |
Description |
Vaccine Name/Description |
24 |
Anthrax |
Anthrax |
19 |
BCG |
Bacillus of Calmette & Guerin |
27 |
Botulinum antitoxin |
Botulinum antitoxin |
26 |
Cholera |
Cholera |
29 |
CMVIG |
Cytomegalovirus immune globulin, intravenous |
12 |
Diphtheria antitoxin |
Diphtheria antitoxin |
28 |
DT(pediatric) |
Diphtheria & tetanus toxoids (pediatric) |
20 |
DTaP |
Diphtheria-tetanus-acellular pertussis |
50 |
Dtap-Hib |
DTaP - Haemophilus influenzae type b conjugate |
01 |
DTP |
Diphtheria-tetanus-pertussis |
22 |
DTP-Hib |
DTP-Haemophilus influenzae type b conjugate |
30 |
HBIG |
Hepatitis B immune globulin |
31 |
Hep A - pediatric |
Hepatitis A |
52 |
Hep A - adult |
Hepatitis A |
08 |
Hep B - adolescent or pediatric |
Hepatitis B--adolescent or pediatric |
42 |
Hep B- adolescent/high risk infant |
Hepatitis B--adolescent/high risk infant |
43 |
Hep B-adult |
Hepatitis B--adult |
44 |
Hep B-dialysis |
Hepatitis B--dialysis |
45 |
Hep B-other or unspecified |
Hepatitis B--other or unspecified |
17 |
Hib-unspecified |
Haemophilus influenzae type b conjugate--unspecified |
46 |
Hib-PRP-D |
Haemophilus influenzae type b conjugate--PRP-D |
47 |
Hib-HbOC |
Haemophilus influenzae type b conjugate--HbOC |
48 |
Hib-PRP-T |
Haemophilus influenzae type b conjugate--PRP-T |
49 |
Hib-PRP-OMP |
Haemophilus influenzae type b conjugate--PRP-OMP |
51 |
Hib-Hep B |
Haemophilus influenzae type b conjugate - Heb-B |
14 |
IG |
Immune globulin |
15 |
Influenza--split (incl. purified surface antigen) |
Influenza--split (incl. purified surface antigen) |
16 |
Influenza--whole |
Influenza--whole |
10 |
IPV |
Poliovirus vaccine, inactivated |
39 |
Japanese encephalitis |
Japanese encephalitis |
03 |
MMR |
Measles-mumps-rubella |
04 |
M/R |
Measles & rubella |
05 |
Measles |
Measles |
32 |
Meningococcal |
Meningococcal |
07 |
Mumps |
Mumps |
11 |
Pertussis |
Pertussis |
23 |
Plague |
Plague |
33 |
Pneumococcal |
Pneumococcal |
02 |
OPV |
Poliovirus vaccine, oral |
18 |
Rabies--intramuscular injection |
Rabies--intramuscular injection |
40 |
Rabies--intradermal injection |
Rabies--intradermal injection |
34 |
RIG |
Rabies immune globulin |
06 |
Rubella |
Rubella |
38 |
Rubella/Mumps |
Rubella & Mumps |
09 |
Td (Adult) |
Tetanus-diphtheria |
35 |
Tetanus toxoid |
Tetanus toxoid |
13 |
TIG |
Tetanus immune globulin |
25 |
Typhoid--oral |
Typhoid--oral |
41 |
Typhoid--parenteral |
Typhoid--parenteral |
21 |
Varicella |
Varicella |
36 |
VZIG |
Varicella zoster immune globulin |
37 |
Yellow fever |
Yellow fever |
The codes in HL7 table 0292 represent the initial content of the external code set CVX. Since immunizations may have to be added to this table more quickly than new versions of HL7 are released, this code system will be maintained by the Centers for Disease Control and Prevention. (Contact the Chief, Systems Development Branch, National Immunization Program, Centers for Disease Control and Prevention, 1600 Clifton Road, MS E-62,Atlanta, GA 30333; (404) 639-8245) http://222.cdc.gov/nip/home.html. When using this code system to identify vaccines, the coding system component of the CE field should be valued as "CVX", not as "HL70292."